November 8-9th, 2010 in Philadelphia, PA ~
HEAR how leading companies are defining and implementing a formal framework of corporate risk management
ATTAIN strategies to place risk management more in connection with benefits
EXAMINE the use of quantitative and qualitative methods to better balance benefit-risk
MASTER global regulatory authorities’ evolving expectations
UNDERSTAND how to improve clinical trial safety and surveillance
LISTEN to practical FDAAA and REMS case studies from industry leaders
LEARN how others are optimizing Electronic Health Records for pro-active pharmacovigilance
DISCUSS the opportunities and challenges of linking pre-market and post-market data
INTEGRATE drug safety knowledge longitudinally across a compound’s lifecycle
[More]
